From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
Articles on TGA
Displaying 21 - 40 of 90 articles
Governments and health bodies agree: it’s time for action on vape imports and sale. But which option will they choose?
The risk of a severe allergic reaction when pholcodine is combined with common medicines used in anaesthesia has lead to their recall in Australia.
Australians bought more than 65 million packs of paracetamol pain relief last year. TGA efforts to reduce its potential harms will need to take those who use it to manage pain into consideration.
If the crisis worsens, more people will ask, how did this happen? The answer will be simple: governments made good laws, but they did not enforce them.
The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
Regulators are currently reviewing the safety and efficacy data of the Pfizer vaccine for five to 11 year olds before deciding whether to approve its use in this age group.
In short, it’s because the texts do not constitute ‘advertising’ – a good reason for the legislation to be revisited and widened.
Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
The Moderna vaccine has been provisionally approved by the Therapeutic Goods Administration for use in Australia, with one million doses due in the second half of September, which will go to pharmacies.
Whipping cream canisters contain nitrous oxide, which some people use to get high. But going ahead with a proposal before the TGA to ban them altogether would be an overreaction.
One study found antibody levels were significantly higher in people who received one dose of AstraZeneca then a Pfizer booster dose.
A serious event such as a blood clot could be caused by an underlying medical condition, a medication the person was taking at the time, or some other factor unrelated to the vaccine.
COVID-19 has resulted in higher than normal levels of medicine shortages. Here’s what to do if your local pharmacy is out of stock.
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
A few simple pointers can help you spot a quality mask from a dud.
Amyl nitrite, known as poppers, can now legally be sold in pharmacies. But don’t expect to see it stocked any time soon. No product has yet passed Australia’s manufacturing and testing process.
The proposed Australian ban of some types of breast implants is too little, too late. It also reveals regulatory failures that need to be fixed if Australian consumers are to be protected.
Who should be legally responsible when 3D printed devices fail? Proposed changes to the Therapeutic Goods Administration’s regulatory framework have the potential to settle that question.
Top contributors
-
Health activist, Medreach Pty Ltd., Bond University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor, School of Law, University of Canberra
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
NHMRC Postgraduate Scholar and Fulbright Alumna in Public Health Policy, Monash University
-
Associate Professor of Law, Bond University
-
Lecturer in Law, Sydney Law School, University of Sydney
-
Adjunct Associate Professor, UNSW
-
Postdoctoral Research Fellow, National Drug and Alcohol Research Centre, UNSW
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Associate Professor of Pharmacology, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
Research Affiliate, The University of Sydney, University of Sydney
-
Clinical pharmacist and Scientia Associate Professor at the National Drug and Alcohol Research Centre, UNSW
-
Professor - Emerging Technologies (Stem Cells) at The University of Melbourne and Group Leader - Stem Cell Ethics & Policy at the Murdoch Children's Research Institute, The University of Melbourne